The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Stealth PLA-PEG Nanoparticles as Protein Carriers for Nasal Administration
Abstract
Purpose The aim of the study was to encapsulate a model protein antigen, tetanus toxoid (TT), within hydrophobic (PLA) and surface hydrophilic (PLA-PEG) nanoparticles and to evaluate the potential of these colloidal carriers for the transport of proteins through the nasal mucosa. Methods TT-loaded nanoparticles, prepared by a modified water-in-oil-in-water solvent evaporation technique, were characterized in their size, zeta potential and hydrophobicity. Nanoparticles were also assayed in vitro for their ability to deliver active antigen for extended periods of time. Finally, 125I-TT-loaded nanoparticles were administered intranasally to rats and the amount of radioactivity recovered in the blood compartment, lymph nodes and other relevant tissues was monitored for up to 48 h. Results PLA and PLA-PEG nanoparticles had a similar particle size (137-156 nm) and negative surface charge, but differed in their surface hydrophobicity: PLA were more hydrophobic than PLA-PEG nanoparticles. PLA-PEG nanoparticles, especially those containing gelatine as an stabilizer, provided extended delivery of the active protein. The transport of the radiolabeled protein through the rat nasal mucosa was highly affected by the surface properties of the nanoparticles: PLA-PEG nanoparticles led to a much greater penetration of TT into the blood circulation and the lymph nodes than PLA nanoparticles. Furthermore, after administration of 125I-TT-loaded PLA-PEG nanoparticles, it was found that a high amou…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This layer of PEG acts as a barrier and reduces the interactions with foreign molecules by steric and hydrated repulsion, giving enhanced shelf stability [22].”
From Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier (2011) · cites this paper as [22]
Citations
Cites
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V. S., Torchilin, V. P., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,951
Self-citationEldridge, J. H., Hammond, C., Meulbroek, J. A., Staas, J. K., Gilley, R. M., & Tice, T. R. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90133-e · Cited by 689
Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System
Bazile, D., Prud'homme, C., Bassoullet, M., Marlard, M., Spenlehauer, G., & Veillard, M. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840420 · Cited by 635
The role of nasopharyngeal lymphoid tissue
Kuper, C. F., Koornstra, P. J., Hameleers, D. M. H., Biewenga, J., Spit, B. J., Duijvestijn, A. M., Vriesman, P. J. C. V. B., & Sminia, T. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90158-4 · Cited by 537
The Oral Absorption of Micro- and Nanoparticulates: Neither Exceptional Nor Unusual
Florence, A. T. (1997) · Pharmaceutical Research · doi:10.1023/a:1012029517394 · Cited by 498
Stolnik, S., Dunn, S. E., Garnett, M. C., Davies, M. C., Coombes, A. G. A., Taylor, D. C., Irving, M. P., Purkiss, S. C., Tadros, T. F., Davis, S. S., et al. (1994) · Pharmaceutical Research · doi:10.1023/a:1018931820564 · Cited by 292
Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres
Blanco, M., & Alonso, M. J. (1997) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00056-8 · Cited by 270
Self-citationPeracchia, M. T., Gref, R., Minamitake, Y., Domb, A. J., Lotan, N., & Langer, R. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01597-0 · Cited by 266
Self-citationDeterminants of Release Rate of Tetanus Vaccine from Polyester Microspheres
Alonso, M. J., Cohen, S., Park, T. G., Rk, G., Siber, G. R., & Langer, R. (1993) · Pharmaceutical Research · doi:10.1023/a:1018942118148 · Cited by 223
Self-citationAlmeida, A. J., & Alpar, H. O. (1996) · Journal of drug targeting · doi:10.3109/10611869609015965 · Cited by 117
Flagged first, then by citations
Research works printed but not linked: 5
- D. T. O'Hagan. Clin. Pharmacokinet. 22:335–344 (1992).
- P. Wüthrich and P. Buri. Pharm. Acta Helvetiae 64:322–331 (1989).
- M. J. Alonso, B. Villamayor, M. Tobío, S. Schwendeman, R. K. Gupta, G. Siber, and R. Langer. Proceed. Intern. Symp. Rel. Bioact. Mater. 23:825–826 (1996).
- M. Tobío and M. J. Alonso. Proceed. Intern. Symp. Rel. Bioact. Mater. 24:425–426 (1997).
- A. T. Florence and P. U. Jani. Pharmaceutical Particulate Carriers, Marcel Dekker, New York, 1993, pp. 65–108.
Cited by
Sorted by citations
Items 301–400 of 401
Nanoparticle-based delivery of an anti-proliferative metal chelator to tumor cells
Kang, Y.-K., Kuo, C.-F., & Majd, S. (2017) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2017.8036824 · Cited by 9
Interpolyelectrolyte Complexes as an Emerging Technology for Pharmaceutical Delivery of Polypeptides
Fay, J. M., & Kabanov, A. V. (2022) · Reviews and Advances in Chemistry · doi:10.1134/s2634827622600177 · Cited by 10
Prajapati, B. G., Prajapati, V. D., Basu, B., Kendre, P. N., Mukherjee, S., Pal, T., Kundu, M., Singh, S. K., Bhattacharya, S., Dharmameher, J. B., et al. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95171-5.00010-8 · Cited by 9
Synthesis and characterization of polylactic acid microspheres via emulsion-based processing
Damptey, R., Torres, S., Cummings, L., & Mohan, R. V. (2023) · MRS Advances · doi:10.1557/s43580-023-00634-x · Cited by 9
Cong, Q., Lin, L., Biao, Q., Xu, C., & Zhang, X. (2021) · Cancer Management and Research · doi:10.2147/cmar.s279831 · Cited by 9
Nanocarriers Overcoming the Nasal Barriers: Physiological Considerations and Mechanistic Issues
Almeida*, A. J., & Florindo, H. F. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849735292-00117 · Cited by 9
Application of surface activity in therapeutics
(2005) · Studies in interface science · doi:10.1016/s1383-7303(05)80047-x · Cited by 9
Kumar, S., Singh, S., Quadir, S. S., Joshi, G., Chouhan, M., Puri, D., & Choudhary, D. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18915-9.00004-5 · Cited by 9
Current Analytical Methods Used in the In Vitro Evaluation of Nano-Drug Delivery Systems
Nagvekar, A. A., Trickler, W. J., & Dash, A. K. (2009) · Current Pharmaceutical Analysis · doi:10.2174/157341209789649122 · Cited by 8
Wu, Y. F., Che, F.-B., & Chen, J. (2008) · Journal of Applied Polymer Science · doi:10.1002/app.28723 · Cited by 8
Application of Chitosan in Oral Drug Delivery
Eftekhari, R. B., Maghsoudnia, N., Samimi, S., & Dorkoosh, F. A. (2019) · Springer eBooks · doi:10.1007/978-981-15-0263-7_2 · Cited by 8
Stealth Engineering for In Vivo Drug Delivery Systems
Mohapatra, A., Morshed, B. I., Haggard, W. O., & Smith, R. A. (2015) · Critical Reviews in Biomedical Engineering · doi:10.1615/critrevbiomedeng.2016016141 · Cited by 7
Gupta, R., & Mohanty, S. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.09.012 · Cited by 7
Drug Delivery: Polymers in the Development of Controlled Release Systems
Campbell, S., & Smeets, N. M. B. (2019) · Polymers and polymeric composites · doi:10.1007/978-3-319-95987-0_20 · Cited by 7
pH-induced micellization of biodegradable block copolymers containing sulfamethazine
Shim, W. S., Lee, J. S., & Lee, D. S. (2005) · Macromolecular Research · doi:10.1007/bf03218464 · Cited by 7
Yoncheva, K., Doytchinova, I. A., & Irache, J. M. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639040903443434 · Cited by 6
Preparation and Characterization of Poly(Lactic Acid) Nanoparticles for Pharmaceutical Use
Hirsjärvi, S. (2008) · Työväentutkimus Vuosikirja · Cited by 6
Beura, S. K., Maharaj, S., Kumari, N., Yadav, R., Sahu, M., Khilar, L. R., Yadav, N., Sahoo, G., Panigrahi, A. R., Yadav, P., et al. (2024) · Nanotechnology in the life sciences · doi:10.1007/978-3-031-72467-1_14 · Cited by 5
Ragab, E. M., Gamal, D. M. E., Elnajjar, F. F., Elkomy, H. A., Ragab, M. A., Elantary, M. A., Basyouni, O. M., Moustafa, S. M., El-Naggar, S. A., & Elsherbiny, A. S. (2025) · Discover Oncology · doi:10.1007/s12672-025-01846-3 · Cited by 5
Formation of MPEG-PLLA block copolymer microparticles using compressed carbon dioxide
Jung, I.-I., Haam, S., Lim, G., & Ryu, J.-H. (2011) · Korean Journal of Chemical Engineering · doi:10.1007/s11814-011-0008-6 · Cited by 5
Nishino, S., Kitamura, Y., Kishida, A., & Yoshizawa, H. (2005) · Macromolecular Bioscience · doi:10.1002/mabi.200500124 · Cited by 5
Drug Delivery: Polymers in the Development of Controlled Release Systems
Campbell, S., & Smeets, N. M. B. (2018) · Polymers and polymeric composites · doi:10.1007/978-3-319-92067-2_20-1 · Cited by 5
Synthesis and pH-dependent micellization of sulfonamide-modified diblock copolymer
Pal, R. R., Kim, M.-S., & Lee, D. S. (2005) · Macromolecular Research · doi:10.1007/bf03218483 · Cited by 5
Biocompatible Nanoparticulate Systems for Tumor Diagnosis and Therapy
Sadoqi, M., Kumar, S., Lau‐Cam, C. A., & Saxena, V. (2003) · Nanotechnologies for the Life Sciences · doi:10.1002/9783527610419.ntls0022 · Cited by 5
PEGylated Nanocarriers for Drug Delivery Applications
Chime, S. A., & Momoh, M. A. (2025) · Springer eBooks · doi:10.1007/978-981-97-7316-9_4 · Cited by 4
Comparison of Different Aliphatic Polyester-Based Microparticles as Protein Delivery Systems
Korzhikov-Vlakh, V. A., Sinitsyna, E., Stepanova, M., Korzhikova‐Vlakh, E., & Tennikova, T. B. (2025) · Polymers · doi:10.3390/polym17192676 · Cited by 4
NANOPARTICULATE DRUG DELIVERY SYSTEMS: PROMISING APPROACHES FOR DRUG DELIVERY
Lankalapalli, S., Routhu, K. C., Ojha, S., & Tenneti, V. S. V. K. (2014) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v0i0.883 · Cited by 4
Fabrication and Optimization of Dp44mT-Loaded Nanoparticles
Holley, C. K., Alkhalifah, S., & Majd, S. (2018) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2018.8513598 · Cited by 4
Figueiredo, B. S., Ferreira, J. N. D. S., Vasconcelos, V. V. V., de Souza, P. P., Angeli, R. V. D., & Paniagua, C. E. D. S. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.94176 · Cited by 4
Polymeric Nanoparticles, Magnetic Nanoparticles and Quantum Dots: Current and Future Perspectives
Ali, J., Md, S., Baboota, S., & Sahni, J. K. (2012) · Springer eBooks · doi:10.1007/978-3-642-29265-1_4 · Cited by 4
Wang, C., Lin, H., Chen, Y. Y., & Lu, Y. H. (2013) · Advanced materials research · doi:10.4028/www.scientific.net/amr.796.92 · Cited by 3
Nanoparticulate Delivery Systems
De, A., Bose, R., Kumar, A., & Mozumdar, S. (2013) · Springer briefs in molecular science · doi:10.1007/978-81-322-1689-6_10 · Cited by 3
Cationic Polymers for Intracellular Delivery of Proteins
Coué, G. M. J. P. C., & Engbersen, J. F. J. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781782620105-00356 · Cited by 3
Mucosal Immunization Using Polyester-Based Particulate Systems
Gaspar, D. P., Peres, C., Florindo, H. F., & Almeida, A. J. (2016) · Pan Stanford eBooks · doi:10.1201/b20045-17 · Cited by 3
Physical Characterization of Nanoparticles
Haskell, R. J. (2006) · Drugs and the pharmaceutical sciences · doi:10.1201/9780849374555.ch5 · Cited by 3
Bioabbaubare polymere Mikro- und Nanopartikel als Proteinlieferungs-Depotsysteme
Cai, C. (2007) · Publikationsserver (Universitat Marburg) · doi:10.17192/z2007.0537 · Cited by 3
PLGA, a Hauler for Anticancer Drugs: Review
Garg, A., Komal, Gupta, P., Sachin, S., Sharma, S., Kumar, S., Kumar, S., Urvashi, Kaur, R., Kriplani, P., et al. (2024) · Current Cancer Therapy Reviews · doi:10.2174/0115733947284281240129065536 · Cited by 2
Therapeutic and Pharmaceutical Applications of PEGylated Nano-Carriers
Shakeri, R., Mirjalili, S. Z., Karakuş, C. Ö., & Safavi, M. (2025) · Springer eBooks · doi:10.1007/978-981-97-7316-9_18 · Cited by 3
Darwish, M. M., Khali, W. M., & Mohamad, E. A. (2026) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2026.06.001 · Cited by 2
Basic concepts and advances in hydrogel and nanogel formulations
Sahu, P. K., Kashaw, S. K., Kashaw, V., Begum, J. P. S., & Dahiya, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-819979-4.00001-5 · Cited by 2
Nanostructures Overcoming the Nasal Barrier: Protein and Peptide Delivery Strategies
Prego, C., & Goycoolea, F. M. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849735292-00133 · Cited by 2
Coué, G. M. J. P. C., Hermanns, I., Unger, R. E., Kirkpatrick, C. J., & Engbersen, J. F. J. (2013) · ChemMedChem · doi:10.1002/cmdc.201300307 · Cited by 2
Targeted cancer therapies: an overview
Najar, I. A., Kankala, R. K., & Johri, R. K. (2012) · International Journal of Life Sciences · doi:10.3126/ijls.v6i1.6085 · Cited by 2
Nanoaggregates of ABC-type triple hydrophilic block copolymers by binding of cationic surfactant
Khanal, A., Yusa, S., & Nakashima, K. (2008) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2008.01.043 · Cited by 2
PLA and PLGA nanoarchitectonics for improving anti-infective drugs efficiency
Chifiriuc, M. C., Fufă, O. M., Grumezescu, V., Andronescu, E., Grumezescu, A. M., & Holban, A. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-42864-4.00013-0 · Cited by 2
12. Biodegradable polymer nanoparticles as protein delivery systems
Peppas, N. A., Duncan, R., Wnek, G. E., Hoffman, A. S., Gao, G. H., Kim, S. W., Lee, D. S., Hadjiargyrou, M., Touitou, E., Ainbinder, D., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.024 · Cited by 2
Labiris, N. R., Bosco, A. P., & DOLOVICH, M. B. (2006) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781860949074_0017 · Cited by 2
Lorenzo-Abalde, S., & González‐Fernández, Á. (2016) · Frontiers in nanobiomedical research · doi:10.1142/9789813140479_0010 · Cited by 2
Biomaterials for Engineering Immune Responses
Jhunjhunwala, S. (2018) · Journal of the Indian Institute of Science · doi:10.1007/s41745-018-0063-7 · Cited by 2
Smart Biodegradable Polymeric Nanoparticles
Malviya, N., Malviya, S., Saxena, R., Chauhan, V., & Dhere, M. (2022) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/978-1-7998-8908-3.ch011 · Cited by 2
Exploiting Nanocarriers for Combination Cancer Therapy
Kong, Y. W., Dreaden, E. C., Hammond, P. T., & Yaffe, M. B. (2016) · Fundamental biomedical technologies · doi:10.1007/978-3-319-43525-1_16 · Cited by 2
MRI Contrast Agents Based on Inorganic Nanoparticles
Na, H. B., & Hyeon, T. (2011) · Wiley eBooks · doi:10.1002/9780470767047.ch13 · Cited by 2
DESENVOLVIMENTO DE NANOPARTÍCULAS DE PLA E PLA-PEG PARA ADMINISTRAÇÃO INTRANASAL DE ZIDOVUDINA
Mainardes, R. M. (2007) · Americanae (AECID Library) · Cited by 2
An, J., Li, X., Li, Z., Wang, J., & Pan, Y. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04417-y · Cited by 3
Study on the Preparation of Steady-State Chitosan Nanoparticle as Silk-Fabric Finishing Agent
Wang, C. H., Lin, H., & Chen, Y. Y. (2011) · Advanced materials research · doi:10.4028/www.scientific.net/amr.175-176.745 · Cited by 1
Recent Patents on Oral Vaccine Design
Mangal, S., Garg, N. K., Mounavya, A., Sahu, T., & Tyagi, R. K. (2009) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/187221409789104728 · Cited by 1
Nanoparticles as Adjuvant-Vectors for Vaccination
Espuelas, S., Gamazo, C., Blanco‐Prieto, M. J., & Irache, J. M. (2007) · CRC Press eBooks · doi:10.1201/9781420008449.ch20 · Cited by 1
Overview of Polyester Nanosystems for Nasal Administration
Vhora, I., Patil, S., Patel, H., Amrutiya, J., Lalani, R., & Misra, A. R. (2016) · Pan Stanford eBooks · doi:10.1201/b20045-11 · Cited by 1
The Biological and Biomedical Nanoparticles-Applications
Saboktakin, M. R. (2017) · International Journal of Molecular Biology Open Access · doi:10.15406/ijmboa.2017.02.00019 · Cited by 1
Functional Nanogels and Hydrogels: A Multipronged Nanotherapy in Drug Delivery and Imaging
Sahu, P. K., Kashaw, S. K., Kashaw, V., & Iyer, A. K. (2023) · Springer eBooks · doi:10.1007/978-981-99-0538-6_11 · Cited by 1
Pharmaceutics and new material
Li, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15793-6.00006-8 · Cited by 1
Effect of topical Paclitaxel using PEG/PLGA polymer on the animal model of cervical cancer
Kim, C. J., Lee, Y. S., Lee, K. H., Jeong, B., Kim, T. W., Kang, T. H., Kim, H. S., & Park, J. S. (2008) · Korean Journal of Gynecologic Oncology · doi:10.3802/kjgo.2008.19.1.68 · Cited by 1
Stimuli‐Responsive Smart Nanoparticles for Biomedical Application
De, A., Mishra, S. K., & Mozumdar, S. (2014) · Advanced Healthcare Materials · doi:10.1002/9781118774205.ch1 · Cited by 1
Optimisation of Drug Delivery: 11. Delivery of Therapeutic Peptides and Proteins
Prankerd, R. J., & Benson, H. A. E. (1999) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr199929120 · Cited by 1
Innovative therapeutics: from molecules to medicines
Jiskoot, W., & Santi, P. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.185 · Cited by 1
Fabrication and modification of biological materials utilizing shear flow system
Ji, S. (2013) · Michigan State University Libraries · doi:10.25335/5ak2-c953 · Cited by 1
Surface Mmodification of Poly(DL-lactide-co-glycolide) Nanoparticle
Oh, Y.-M., Jung, T.-K., Chi, S., & Shin, B.-C. (2003) · Journal of the Korean Chemical Society · doi:10.5012/jkcs.2003.47.6.601 · Cited by 1
Nanotecnología Farmacéutica: Una galénica emergente
Jato, J. L. V. (2006)
Ciencia y salud global: la brecha del desarrollo
Fernández, M. J. A. (2010)
Desarrollo de nuevos vehículos para la administración de vacunas genéticas
Csaba, N. (2005) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Phagocytic Uptake of Surface modified PLGA Microspheres Using Dendritic Cell
Kim, J., Lee, Y.-S., Lee, J.-G., Park, J., Lee, J.-K., Chung, Y., & Han, K. (2011) · Journal of Pharmaceutical Investigation · doi:10.4333/kps.2011.41.3.185
Nanoparticles: a boon for modernisation of drug delivery: a review
Khan, M. S., & Gowda, D. V. (2011) · International Journal of Nanoparticles · doi:10.1504/ijnp.2011.043501
In Vitro Simulation of In Vivo Performance of Oral Dosed Nanoparticulate Insulin
Golkaran, D. (2013) · QSpace (Queen's University Library)
Kim, H., & Ishihara, K. (2014) · Biomaterials & biomedical engineering · doi:10.12989/bme.2014.1.2.095
Dendrimer Nanoconjugates And Their Oral Inhalation Formulations For Lung Cancer Therapy
Zhong, Q. (2016) · Human Biology
Polyester Nano- and Microsystems for Vaccine Delivery
Sharma, R. K., Mody, N., Dubey, S., Agrawal, U., & Vyas, S. P. (2016) · Pan Stanford eBooks · doi:10.1201/b20045-16
Statements on Societal Implications
Kalil, T. A., Gingrich, N., Armstrong, J. A., Brown, J., Duguid, P., Yonas, G., Picraux, S. T., Crow, M. M., Sarewitz, D., Garcés, J., et al. (2001) · Springer eBooks · doi:10.1007/978-94-017-3012-9_6
Self-citationPeroral Polyester Drug Delivery Systems
Durán‐Lobato, M., Holgado, M. A., Álvarez‐Fuentes, J., Arias, J. L., Arévalo, M. F., & Martín‐Banderas, L. (2016) · Pan Stanford eBooks · doi:10.1201/b20045-10
Block Ionomer Complex Formulations For In Vivo Protein Delivery
Jiang, Y. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/x27r-1j68
Peptides, Proteins and Antibodies
Lalatsa, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9164-4_19
Shinwary, S. S. (2012) · MacSphere (McMaster University) · doi:10.71548/16096
SOLID LIPID NANOPARTICLES: A NOVEL POTENTIAL CARRIER APPROACH
Rewar, S., Mirdha, D., & Rewar, P. (2014)
Synthesis of polyanhydrides for controlled drug delivery
Vogel, B. M. (2003) · doi:10.31274/rtd-20200803-399
(2015) · CRC Press eBooks · doi:10.1201/b18211-5
Bohidar, H. B., & Rawat, K. (2017) · doi:10.1002/9783527810444.ch9
Methods and Protocols for the Synthesis of PEGylated Pharmaceutical Nanocarriers
Ali, A. A., Tekade, R. K., & Mansour, R. S. H. (2025) · Springer eBooks · doi:10.1007/978-981-97-7316-9_2
Mycobacterium tuberculosis -infected macrophages accumulate more nanoparticlesPreprint
Pochet, A., Bourguignon, T., Grandé, A., Godinez-Leon, J. A., Fine, J., Brodin, P. M., Machelart, A., & Gref, R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.15.654063
Self-citationHosseini, H., Weemes, T., Fontenot, K., Jones, C., Stanciu, C., & Richards, P. (2026) · Industrial & Engineering Chemistry Research · doi:10.1021/acs.iecr.5c04102
Costa, M. C., Garcia, F. G., Flores, E. M., Acero, G., Ramirez, M. A., & Simoes, A. Z. (2026) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2026.117174
Binding of Vaccine and Poly(DL-lactide-co-glycolide) Nanoparticle Modified with Anionic Surfactant
(2004) · Journal of Korean Pharmaceutical Sciences · doi:10.4333/kps.2004.34.3.177
Kiill, C. P. (2012) · Americanae (AECID Library)
Metadata
- Authors
- Tobío, M., Gref, R., Sánchez, A., Langer, R., & Alonso, M. J.
- Affiliations
- Universidade de Santiago de Compostela (ES)
- Laboratoire de Chimie-Physique Macromoléculaire (FR)
- Massachusetts Institute of Technology (US)
- Venue
- Pharmaceutical Research
- Published
- 1998-02
- Volume
- 15
- Issue
- 2
- Pages
- 270-275
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W1494872149
- Cited by
- 402
- References
- 19
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 10 · 2023: 9 · 2022: 4 · 2021: 6 · 2020: 7 · 2019: 15 · 2018: 14 · 2017: 15 · 2016: 22 · 2015: 13 · 2014: 25 · 2013: 24 · 2012: 31
- FWCI
- 10.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Pharmaceutical Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM026698, GM 26698)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- polylactic acid, protein encapsulation, tetanus toxoid, nasal mucosa, intranasal drug delivery, carrier proteins, surface hydrophobicity, lymph node uptake, blood circulation, colloidal carriers
- MeSH terms
- Administration, Intranasal, Animals, Drug Carriers, Lactates, Microscopy, Electron, Particle Size, Polyethylene Glycols, Tetanus Toxoid, Tissue Distribution, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review